Brain Tumors
Chapter
First Online:
Abstract
Brain tumor patients constitute a heterogeneous population, representing a wide variety of pathologies and clinical presentations. From a neurocritical care perspective, brain tumor patients will require treatment of cerebral edema, seizures, and/or hydrocephalus. Attention to the neurologic exam is critical, as subtle changes in clinical status often signal an impending, and after catastrophic, clinical deterioration. In addition, excellent critical care management is necessary in both the pre- and postoperative period and has been demonstrated to significantly reduce morbidity and mortality.
Keywords
Brain tumors ICU Cerebral edema Seizures Hydrocephalus DVT PEReferences
- 1.Ostrom QT, Gittleman H, Farah P, et al. Neuro-oncology CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. 2013;12:28–36.Google Scholar
- 2.Nussbaum ES, Djalilian HR, Cho KH, Hall WA. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer. 1996;78:1781–8.Google Scholar
- 3.Lacy J, Saadati H, Yu JB. Complications of brain tumors and their treatment. Hematol Oncol Clin North Am. 2012;26:779–96. doi: 10.1016/j.hoc.2012.04.007.CrossRefPubMedGoogle Scholar
- 4.Esquenazi Y, Lo VP, Lee K. Critical care management of cerebral edema in brain tumors. J Intensive Care Med. 2015; doi: 10.1177/0885066615619618.PubMedGoogle Scholar
- 5.Pruitt AA. Medical management of patients with brain tumors. Continuum (Minneap Minn). 2015;21:314–31. doi: 10.1212/01.CON.0000464172.50638.21.Google Scholar
- 6.Ryken TC, McDermott M, Robinson PD, et al. The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neuro-Oncol. 2010;96:103–14. doi: 10.1007/s11060-009-0057-4.CrossRefGoogle Scholar
- 7.Arrillaga-Romany I, Norden AD. Antiangiogenic therapies for glioblastoma. CNS Oncol. 2014;3:349–58. doi: 10.2217/cns.14.31.CrossRefPubMedGoogle Scholar
- 8.Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the quality standards Subcommittee of the American Academy of Neurology. Neurology. 2000;54:1886–93.CrossRefPubMedGoogle Scholar
- 9.Wen PY, Schiff D, Kesari S, et al. Medical management of patients with brain tumors. J Neuro-Oncol. 2006;80:313–32. doi: 10.1007/s11060-006-9193-2.CrossRefGoogle Scholar
- 10.Maschio M, Dinapoli L. Patients with brain tumor-related epilepsy. J Neuro-Oncol. 2012;109:1–6. doi: 10.1007/s11060-012-0867-7.CrossRefGoogle Scholar
- 11.Sayegh ET, Fakurnejad S, Oh T, et al. Anticonvulsant prophylaxis for brain tumor surgery: determining the current best available evidence. J Neurosurg. 2014;121:1139–47. doi: 10.3171/2014.7.JNS132829.CrossRefPubMedGoogle Scholar
- 12.Hoefnagel D, Kwee LE, van Putten EHP, et al. The incidence of postoperative thromboembolic complications following surgical resection of intracranial meningioma. A retrospective study of a large single center patient cohort. Clin Neurol Neurosurg. 2014;123:150–4. doi: 10.1016/j.clineuro.2014.06.001.CrossRefPubMedGoogle Scholar
- 13.Eisenring CV, Neidert MC, Sabanés Bové D, et al. Reduction of thromboembolic events in meningioma surgery: a cohort study of 724 consecutive patients. PLoS One. 2013;8:e79170. doi: 10.1371/journal.pone.0079170.CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Alshehri N, Cote DJ, Hulou MM, et al. Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis. J Neuro-Oncol. 2016; doi: 10.1007/s11060-016-2259-x.Google Scholar
Copyright information
© Springer International Publishing AG 2018